Whole Exome Sequencing, Singleton Analysis
Whole Exome Sequencing, Singleton Analysis
Whole Exome Sequencing (WES), Singleton Analysis is a molecular test that captures data from the entire exome with additional coverage for genes with known Mendelian disease associations, to help identify the underlying genetic cause of patient’s unexplained medical condition. This is a phenotype driven analysis, and the curation of variants reported is guided from the patient’s documented phenotype. There is no default option for secondary findings. Patients and families must select whether or not to receive this information as part of the analysis.
The standard WES is a trio analysis that includes the proband and both parents. However, the singleton analysis is available if parents or siblings are unavailable.
Technical Information
The average read depth for whole exome sequnecing is typically greater than 150X. In our experience, greater than 30% of patients have a pathogenic or likely pathogenic finding consistent with the reported phenotype. Reanalysis can be ordered as a separate test for an additional charge.
We recommend further array-based testing to more accurately address the concerns of dosage alterations such as GGC’s cytogenomic microarray – a high resolution, whole genome SNP microarray. Laboratory Directors and Laboratory Genetic Counselors are also available for further consultation regarding the limitations of the NGS and array testing procedures.
Specimen Requirements
Transport Instructions
Associated Tests
Connect With Our Experts
Call 1-800-473-9411 to speak with our team of laboratory genetic counselors for questions or additional information.
Robin Fletcher, MS, CGC
Falecia Thomas, MS, CGC
Alex Finley, MS, CGC
